Palisade Bio Stock Analysis

Palisade Stock Analysis Notes

The company has price-to-book ratio of 0.39. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Palisade Bio recorded a loss per share of 13.26. The entity last dividend was issued on the 18th of July 2019. The firm had 1:15 split on the 8th of April 2024. Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. The company was founded in 2005 and is headquartered in Carlsbad, California. Palisade Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people. To find out more about Palisade Bio contact J Finley at 858 704 4900 or learn more at https://www.palisadebio.com.

Palisade Bio Investment Alerts

Palisade Bio Upcoming and Recent Events

Palisade Largest EPS Surprises

View All Earnings Estimates

Palisade Stock Institutional Investors

Note, although Palisade Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Palisade Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.59 M.

Palisade Profitablity

Management Efficiency

Palisade Bio has return on total asset (ROA) of (0.682) % which means that it has lost $0.682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3596) %, meaning that it created substantial loss on money invested by shareholders. Palisade Bio's management efficiency ratios could be used to measure how well Palisade Bio manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.83. The current Return On Capital Employed is estimated to decrease to -1.08. As of now, Palisade Bio's Fixed Asset Turnover is decreasing as compared to previous years.

Technical Drivers

As of the 27th of February, Palisade Bio holds the Risk Adjusted Performance of (0.06), coefficient of variation of (1,046), and Variance of 113.94. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Palisade Bio, as well as the relationship between them.

Palisade Bio Price Movement Analysis

Palisade Bio Insider Trading Activities

Palisade Bio Outstanding Bonds

Palisade Bio Predictive Daily Indicators

Palisade Bio Forecast Models

Palisade Bio's time-series forecasting models are one of many Palisade Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Palisade Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Palisade Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Palisade shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Palisade Bio. By using and applying Palisade Stock analysis, traders can create a robust methodology for identifying Palisade entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Palisade analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Palisade analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Palisade Bio stock analysis indicators help investors evaluate how Palisade Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Palisade Bio shares will generate the highest return on investment. By understating and applying Palisade Bio stock analysis, traders can identify Palisade Bio position entry and exit signals to maximize returns.

When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.